Long term outcome data from the EORTC 75111-10114 ETF/BCG randomized phase II study: Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer, followed by T-DM1 after progression
-
Published:2022-08
Issue:
Volume:64
Page:100-111
-
ISSN:0960-9776
-
Container-title:The Breast
-
language:en
-
Short-container-title:The Breast
Author:
Wildiers HansORCID,
Meyskens Thomas,
Marréaud Sandrine,
Lago Lissandra Dal,
Vuylsteke PeterORCID,
Curigliano GiuseppeORCID,
Waters SimonORCID,
Brouwers Barbara,
Meulemans Bart,
Sousa BertaORCID,
Poncet Coralie,
Brain Etienne
Subject
General Medicine,Surgery
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献